Leigh C. Jefferies

451 total citations
20 papers, 310 citations indexed

About

Leigh C. Jefferies is a scholar working on Hematology, Immunology and Biochemistry. According to data from OpenAlex, Leigh C. Jefferies has authored 20 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Immunology and 4 papers in Biochemistry. Recurrent topics in Leigh C. Jefferies's work include Blood groups and transfusion (5 papers), Blood transfusion and management (4 papers) and Healthcare Policy and Management (4 papers). Leigh C. Jefferies is often cited by papers focused on Blood groups and transfusion (5 papers), Blood transfusion and management (4 papers) and Healthcare Policy and Management (4 papers). Leigh C. Jefferies collaborates with scholars based in United States, United Kingdom and Sweden. Leigh C. Jefferies's co-authors include Bruce S. Sachais, Donald S. Young, L. E. Silberstein, William G. Kerr, Christopher R. Cogle, John M. Ninos, Kelly L. Drew, Mary Beth Callan, Donna A. Oakley and Urs Giger and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

Leigh C. Jefferies

20 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leigh C. Jefferies United States 11 136 64 50 49 41 20 310
Peter H. Pinkerton Canada 13 180 1.3× 78 1.2× 54 1.1× 26 0.5× 111 2.7× 30 476
Shan Yuan United States 10 117 0.9× 82 1.3× 40 0.8× 51 1.0× 30 0.7× 16 418
Kristen K. Flaharty United States 8 255 1.9× 39 0.6× 45 0.9× 42 0.9× 60 1.5× 9 357
Sarina C. Lowe United States 5 91 0.7× 153 2.4× 19 0.4× 9 0.2× 45 1.1× 10 316
Calvino Cheng Canada 7 63 0.5× 47 0.7× 44 0.9× 15 0.3× 47 1.1× 18 296
David Roxby Australia 14 262 1.9× 291 4.5× 178 3.6× 44 0.9× 110 2.7× 38 704
H. Kjellman Sweden 13 213 1.6× 174 2.7× 21 0.4× 24 0.5× 27 0.7× 20 462
Khalil Al‐Farsi Oman 11 154 1.1× 13 0.2× 41 0.8× 15 0.3× 112 2.7× 35 329
Saad Al‐Ismail United Kingdom 13 99 0.7× 6 0.1× 57 1.1× 23 0.5× 74 1.8× 29 355
Ceri Hirst United Kingdom 15 147 1.1× 15 0.2× 31 0.6× 18 0.4× 176 4.3× 28 573

Countries citing papers authored by Leigh C. Jefferies

Since Specialization
Citations

This map shows the geographic impact of Leigh C. Jefferies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leigh C. Jefferies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leigh C. Jefferies more than expected).

Fields of papers citing papers by Leigh C. Jefferies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leigh C. Jefferies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leigh C. Jefferies. The network helps show where Leigh C. Jefferies may publish in the future.

Co-authorship network of co-authors of Leigh C. Jefferies

This figure shows the co-authorship network connecting the top 25 collaborators of Leigh C. Jefferies. A scholar is included among the top collaborators of Leigh C. Jefferies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leigh C. Jefferies. Leigh C. Jefferies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brody, Robert S., Charles Liss, Heather Wray, et al.. (2015). Effectiveness of a risk-minimization activity involving physician education on metabolic monitoring of patients receiving quetiapine. International Clinical Psychopharmacology. 31(1). 34–41. 9 indexed citations
2.
Ninos, John M., Leigh C. Jefferies, Christopher R. Cogle, & William G. Kerr. (2006). The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells. Journal of Translational Medicine. 4(1). 41 indexed citations
3.
Young, Donald S., Bruce S. Sachais, & Leigh C. Jefferies. (2002). Comparative Costs of Treating Adults and Children within Selected Diagnosis-related Groups. Clinical Chemistry. 48(1). 150–160. 6 indexed citations
4.
Young, Donald S., Bruce S. Sachais, & Leigh C. Jefferies. (2002). Effect of Disease Complications on Hospital Costs. Clinical Chemistry. 48(1). 140–149. 11 indexed citations
5.
Jefferies, Leigh C., Bruce S. Sachais, & Donald S. Young. (2001). Blood transfusion costs by diagnosis‐related groupsin 60 university hospitals in 1995. Transfusion. 41(4). 522–529. 31 indexed citations
6.
Callan, Mary Beth, et al.. (2001). Clinical indications for use of fresh frozen plasma in dogs: 74 dogs (October through December 1999). Journal of the American Veterinary Medical Association. 218(9). 1449–1455. 41 indexed citations
7.
Young, Donald S., Bruce S. Sachais, & Leigh C. Jefferies. (2000). Laboratory Costs in the Context of Disease. Clinical Chemistry. 46(7). 967–975. 25 indexed citations
8.
Young, Donald S., Bruce S. Sachais, & Leigh C. Jefferies. (2000). The Costs of Disease. Clinical Chemistry. 46(7). 955–966. 13 indexed citations
9.
Jefferies, Leigh C., et al.. (1999). High deferral rate for maternal–neonatal donor pairs for an allogeneic umbilical cord blood bank. Transfusion. 39(4). 415–419. 14 indexed citations
10.
Jefferies, Leigh C., et al.. (1996). A Team Approach To Decrease Wasted Blood Products. Laboratory Medicine. 27(12). 833.2–837. 3 indexed citations
11.
Biggs, David D., Piotr Kraj, J Goldman, et al.. (1995). Immunoglobulin gene sequence analysis to further assess B-cell origin of multiple myeloma. Clinical and Diagnostic Laboratory Immunology. 2(1). 44–52. 10 indexed citations
12.
Jefferies, Leigh C., et al.. (1995). Immunoglobulin Gene Use by Naturally Occurring Cold Agglutinins. Annals of the New York Academy of Sciences. 764(1). 433–435. 2 indexed citations
13.
Jefferies, Leigh C.. (1994). Transfusion Therapy in Autoimmune Hemolytic Anemia. Hematology/Oncology Clinics of North America. 8(6). 1087–1104. 35 indexed citations
14.
Khaw, Peng T., et al.. (1993). SINGLE INTRAOPERATIVE EXPOSURES TO MITOMYCIN-C (MMC) - LONG-TERM EFFECTS ON SCLERAL CELLULARITY. UCL Discovery (University College London). 2 indexed citations
15.
Jefferies, Leigh C., et al.. (1993). Naturally occurring anti-i/I cold agglutinins may be encoded by different VH3 genes as well as the VH4.21 gene segment.. Journal of Clinical Investigation. 92(6). 2821–2833. 29 indexed citations
16.
Jefferies, Leigh C., et al.. (1992). Idiotypic heterogeneity of VκIII autoantibodies to red blood cell antigens. Clinical Immunology and Immunopathology. 65(2). 119–128. 9 indexed citations
17.
Snyder, Edward L., Richard H. Aster, Andrew Heaton, et al.. (1992). Five‐day storage of platelets in a non‐diethylhexyl phthalate‐plasticized container. Transfusion. 32(8). 736–741. 11 indexed citations
18.
Friedman, David F., et al.. (1991). Structural basis of a conserved idiotope expressed by an autoreactive human B cell lymphoma. Evidence that a VH CDR3 mutation alters idiotypy and specificity. The Journal of Immunology. 147(10). 3623–3631. 9 indexed citations
19.
Jefferies, Leigh C., Freda K. Stevenson, J Goldman, et al.. (1990). Anti‐idiotypic antibodies specific for a pathologic anti‐Pr2 cold agglutinin. Transfusion. 30(6). 495–502. 4 indexed citations
20.
Silberstein, Leslie E., Leigh C. Jefferies, J Goldman, & Steven L. Spitalnik. (1989). [23] Production of carbohydrate-specific human monoclonal antibodies in vitro. Methods in enzymology on CD-ROM/Methods in enzymology. 179. 299–304. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026